Skip to main content

Advertisement

Log in

Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand

  • Molecular Toxicology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Consumers are exposed to pesticide residues and other food contaminants via the diet. Both can exert adverse effects on different target organs via the activation of nuclear receptor pathways. Hepatotoxic effects of the widely used triazole fungicide propiconazole (Pi) are generally attributed to the activation of the constitutive androstane receptor (CAR) or the pregnane X receptor (PXR). We now investigated the effects of Pi on the aryl hydrocarbon receptor (AHR) and possible mixture toxicity when Pi is present in combination with BbF, an AHR ligand. In silico docking simulations indicate that Pi can bind to human AHR. Subsequent dual luciferase reporter gene assays in human HepG2 cells showed that Pi activates the AHR in vitro. This concentration-dependent activation was confirmed by real-time RT-PCR analyses of the model AHR target genes CYP1A1 and CYP1A2 in human HepaRG and HepG2 cells. In addition, induction of CYP1A1 protein levels and enzyme activity were recorded. Similarly, increased mRNA expression and enzyme activity of Cyp1a1 and Cyp1a2 was observed in livers of rats treated with Pi for 28 days via the diet. Gene expression analysis in AHR-knockout HepaRG cells showed no induction of CYP1A1 and CYP1A2, whereas gene expression in CAR-, and PXR-knockout cells was induced. Finally, mixture effects of Pi and BbF were analyzed in human cell lines: modeling of concentration–response curves revealed concentration additivity. In conclusion, our results demonstrate that the triazole Pi is an activator of AHR in silico, in vitro and in vivo and causes additive effects with an established AHR ligand.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

AHR:

Aryl hydrocarbon receptor

AOP:

Adverse outcome pathway

BaP:

Benzo[a]pyrene

BbF:

Benzo[b]fluoranthene

CAR:

Constitutive androstane receptor

CITCO:

6-(4-Chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4dichlorobenzyl)oxime

CYP:

Cytochrome P450

DMSO:

Dimethylsulfoxide

EFSA:

European Food Safety Authority

EROD:

Ethoxyresorufin-O-deethylase

FCS:

Fetal calf serum

HIF-2α:

Hypoxia-inducible factor 2α

IARC:

International Agency for the Research on Cancer

IPA:

Ingenuity pathway analysis

LBD:

Ligand binding domain

LLOQ:

Lower limits of quantification

MTT:

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

PAH:

Polycyclic aromatic hydrocarbon

Pi:

Propiconazole

PPAR:

Peroxisome proliferator-induced receptor

PXR:

Pregnane X receptor

RSLC:

Rapid separation LC

SD:

Standard deviation

TCDD:

2,3,7,8-Tetrachlorodibenzo[p]dioxin

TCPOBOP:

1,4-Bis-[2-(3,5-dichloropyridyloxy)] benzene

tSIM:

Targeted single-ion monitoring

References

Download references

Acknowledgements

The authors thank Jannika Neeb and Inês Aragão for technical assistance as well as Dr. Claudia Luckert, Dr. Josef Rasinger and Dr. Axel Oberemm for helpful guidance with data analysis. This work was supported by the German Federal Institute for Risk Assessment (Grant 1322-499 and 657, PMS and AB) and by Grants from Ministero dell’Istruzione, dell’Università e della Ricerca (MIUR)-“Progetto Eccellenza” (IE). IE gratefully acknowledges departmental “Linea 2-Azione A 2017” funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip Marx-Stoelting.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 227 KB)

Supplementary material 2 (DOCX 22 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Knebel, C., Kebben, J., Eberini, I. et al. Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand. Arch Toxicol 92, 3471–3486 (2018). https://doi.org/10.1007/s00204-018-2321-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-018-2321-x

Keywords

Navigation